IS7821A - Lyfjatöflur sem innihalda tibólón og húðun - Google Patents
Lyfjatöflur sem innihalda tibólón og húðunInfo
- Publication number
- IS7821A IS7821A IS7821A IS7821A IS7821A IS 7821 A IS7821 A IS 7821A IS 7821 A IS7821 A IS 7821A IS 7821 A IS7821 A IS 7821A IS 7821 A IS7821 A IS 7821A
- Authority
- IS
- Iceland
- Prior art keywords
- coatings
- tablets containing
- tibolone
- containing tibolone
- tablets
- Prior art date
Links
- 238000000576 coating method Methods 0.000 title 1
- WZDGZWOAQTVYBX-XOINTXKNSA-N tibolone Chemical compound C([C@@H]12)C[C@]3(C)[C@@](C#C)(O)CC[C@H]3[C@@H]1[C@H](C)CC1=C2CCC(=O)C1 WZDGZWOAQTVYBX-XOINTXKNSA-N 0.000 title 1
- 229960001023 tibolone Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
- A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42774002P | 2002-11-20 | 2002-11-20 | |
| EP02079920 | 2002-11-20 | ||
| EP03796019A EP1565168A1 (en) | 2002-11-20 | 2003-11-13 | Pharmaceutical tablets containing tibolone and a coating |
| PCT/EP2003/050829 WO2004045587A1 (en) | 2002-11-20 | 2003-11-13 | Pharmaceutical tablets containing tibolone and a coating |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS7821A true IS7821A (is) | 2005-04-25 |
Family
ID=32327854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS7821A IS7821A (is) | 2002-11-20 | 2005-04-25 | Lyfjatöflur sem innihalda tibólón og húðun |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20060051420A1 (is) |
| KR (1) | KR20050085024A (is) |
| AR (1) | AR042083A1 (is) |
| CL (1) | CL2003002385A1 (is) |
| CO (1) | CO5590891A2 (is) |
| EC (1) | ECSP055811A (is) |
| HR (1) | HRP20050430A2 (is) |
| IS (1) | IS7821A (is) |
| LV (1) | LV13346B (is) |
| NO (1) | NO20052305L (is) |
| PE (1) | PE20040839A1 (is) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005027879A1 (en) * | 2003-09-24 | 2005-03-31 | Novartis Consumer Health S.A. | Coated tablets |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3751277A (en) * | 1971-03-24 | 1973-08-07 | Dow Chemical Co | Tablet coating process and composition |
| ATE180669T1 (de) * | 1993-03-05 | 1999-06-15 | Akzo Nobel Nv | Verwendung von pregnanderivaten zur behandlung von tumoren |
| WO1995006462A1 (en) * | 1993-08-30 | 1995-03-09 | Warner-Lambert Company | Tablet coating based on a melt-spun mixture of a saccharide and apolymer |
-
2003
- 2003-11-13 HR HR20050430A patent/HRP20050430A2/xx not_active Application Discontinuation
- 2003-11-13 KR KR1020057008863A patent/KR20050085024A/ko not_active Withdrawn
- 2003-11-13 US US10/535,009 patent/US20060051420A1/en not_active Abandoned
- 2003-11-18 CL CL200302385A patent/CL2003002385A1/es unknown
- 2003-11-19 PE PE2003001174A patent/PE20040839A1/es not_active Application Discontinuation
- 2003-11-19 AR ARP030104271A patent/AR042083A1/es not_active Application Discontinuation
-
2005
- 2005-04-25 IS IS7821A patent/IS7821A/is unknown
- 2005-05-11 NO NO20052305A patent/NO20052305L/no not_active Application Discontinuation
- 2005-05-20 EC EC2005005811A patent/ECSP055811A/es unknown
- 2005-06-16 CO CO05058822A patent/CO5590891A2/es unknown
- 2005-06-17 LV LVP-05-72A patent/LV13346B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO5590891A2 (es) | 2005-12-30 |
| PE20040839A1 (es) | 2004-11-17 |
| ECSP055811A (es) | 2005-08-11 |
| CL2003002385A1 (es) | 2005-01-14 |
| AR042083A1 (es) | 2005-06-08 |
| LV13346B (en) | 2005-12-20 |
| KR20050085024A (ko) | 2005-08-29 |
| NO20052305L (no) | 2005-06-07 |
| HRP20050430A2 (en) | 2005-06-30 |
| US20060051420A1 (en) | 2006-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS7594A (is) | Laxófoxifen tafla og húðun hennar | |
| ZA200500432B (en) | Sustained-release tablet comprising reboxetine | |
| GB0229742D0 (en) | Novel compounds and uses thereof | |
| AU2003236991A8 (en) | Representations of processes | |
| GB0221513D0 (en) | Novel compounds and processes | |
| GB0202059D0 (en) | Chemical compositions and methods | |
| SI1551805T1 (sl) | Substituirani gama-fenil-delta-laktami in njihova uporaba | |
| DE60209673D1 (de) | Tablettenbeschichtungen | |
| AU2003284942A8 (en) | Oral extended release tablets and methods of making and using the same | |
| GB0214107D0 (en) | Fires | |
| IS7821A (is) | Lyfjatöflur sem innihalda tibólón og húðun | |
| AU2003268078A8 (en) | Levothyroxine compositions and methods | |
| GB0206223D0 (en) | Sound effects devices | |
| PL376744A1 (pl) | Tabletki farmaceutyczne zawierające tibolon i powłoczkę | |
| GB0211949D0 (en) | Novel compounds compositions and processes | |
| GB0207624D0 (en) | Chemokine and uses thereof | |
| GB0203528D0 (en) | Process and composition | |
| AU2003216442A8 (en) | Enkurin and uses thereof | |
| GB0214108D0 (en) | Fires | |
| PL354856A1 (en) | Tablet base | |
| AU148730S (en) | Tablet | |
| AU148728S (en) | Tablet | |
| AU148729S (en) | Tablet | |
| GB0322371D0 (en) | Coated tablets | |
| GB0325604D0 (en) | Coated tablets |